No CrossRef data available.
Article contents
P0283 - Atypical antipsychotics in epilepsy
Published online by Cambridge University Press: 16 April 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Epilepsy is a neurological disease, always associating psychiatric troubles; these last ones can be permanent – unstable affect, dementia, or transient – delusions, hallucinations. Treatment in these patients is often difficult, because many antipsychotics may determine motor seizures and/or electroencephalographic changes.
Method:
We considered a sample of 35 epileptic patients (21 male and 14 female) with psychotic features, treated with specific antiepileptics and atypical antipsychotics (risperidone, olanzapine, quetiapine). It is well known that DA mediators partially inhibit motor seizures.
Results:
During one year, none of our patients related any increase of the frequency of seizures. Also, we did not highlight electroencephalographic changes in this period. Clinically, patients were assessed using PANSS scale.
Conclusion:
Atypical antipsychotics can be safety utilized in patients with epilepsy, ascertaining a good control of psychotic features, without worsening neurological symptomatology.
- Type
- Poster Session I: Neuroleptics and Antipsychotics
- Information
- European Psychiatry , Volume 23 , Issue S2: 16th AEP Congress - Abstract book - 16th AEP Congress , April 2008 , pp. S164
- Copyright
- Copyright © European Psychiatric Association 2008
You have
Access
Comments
No Comments have been published for this article.